METARAMINOL BITARTRATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Metaraminol Bitartrate, and when can generic versions of Metaraminol Bitartrate launch?
Metaraminol Bitartrate is a drug marketed by Abraxis Pharm, Azurity, Elkins Sinn, Fresenius Kabi Usa, and Gd Searle Llc. and is included in five NDAs.
The generic ingredient in METARAMINOL BITARTRATE is metaraminol bitartrate. There is one drug master file entry for this compound. Additional details are available on the metaraminol bitartrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Metaraminol Bitartrate
A generic version of METARAMINOL BITARTRATE was approved as metaraminol bitartrate by AZURITY on August 24th, 2021.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for METARAMINOL BITARTRATE?
- What are the global sales for METARAMINOL BITARTRATE?
- What is Average Wholesale Price for METARAMINOL BITARTRATE?
Summary for METARAMINOL BITARTRATE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 82 |
| Patent Applications: | 426 |
| DailyMed Link: | METARAMINOL BITARTRATE at DailyMed |
Medical Subject Heading (MeSH) Categories for METARAMINOL BITARTRATE
Anatomical Therapeutic Chemical (ATC) Classes for METARAMINOL BITARTRATE
US Patents and Regulatory Information for METARAMINOL BITARTRATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 080431-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Fresenius Kabi Usa | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 080722-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Azurity | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 211304-001 | Aug 24, 2021 | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Elkins Sinn | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 083363-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Gd Searle Llc | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 086418-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Gd Searle Llc | METARAMINOL BITARTRATE | metaraminol bitartrate | INJECTABLE;INJECTION | 086418-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
